EMCDDA Document Library

Displaying 1 - 10 of 16

no image available

Special measures for vulnerable groups with substance use disorders (SUD) during the Coronavirus epidemic - Norway

This document offers information about coronavirus (COVID-19), harm reduction advice to drug users, infection avoidance advice to drug users, advice to users undergoing OST, and advice to services providing OST.

screenshot

Recommendations for drug users and professionals in mental health and addiction during the COVID-19 pandemic (AMA, Morocco, French)

These are recommendations (in French) written by the Moroccan Association of Addictology, are destined to people who use drugs, mental health and addiction professionals during the COVID-19 pandemic. They include general guidelines, advice for outreach service and on methadone prescriptions, as...

Screenshot

Opioid agonist therapy (OAT) and the COVID-19 pandemic: recommendations of the SSAM (Switzerland)

The Swiss Addiction Medicine association provides recommendations to doctors and services providing OST during the pandemic to ensure continuity of services.

Guidance on contingency planning for people who use drugs and COVID-19 (v1.0) (Scottish Drugs Forum)

How can needle exchange services and opioid substitution therapy be safeguarded in the midst of a novel viral outbreak? Scottish Guidance considers potential disruptions to delivery, and suggests ways of ensuring continuity of services when best practice or ‘service as usual’ might be out of the...

screenshot

Modalités de prescription et délivrance des Traitements de substitution aux Opiacés adaptées à la situation (Féderation Addictions)

This website documents the French regulation that describes how to adapt OST prescriptions during the pandemic.

Publication thumbnail

Health and social responses to drug problems in prisons

This paper contributes to a larger report on health and social responses to drug problems in Europe. The central aim of the paper is to provide an overview for policymakers, health and prison service commissioners, and providers and service users of how prisons may provide a setting for responding...

no image available

Evaluation of Denmark's heroin prescription scheme 2010-12

This document presents the2013 evaluation of Denmark's heroin prescription scheme 2010-12 by the National health Board.

no image available

Long-term opioid agonist treatment participation after first treatment entry is similar across 4 European regions but lower in non-nationals

WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitic C virus infection

WHO estimates that in 2015, 71 million persons were living with chronic hepatitis C virus (HCV) infection worldwide and that 399 000 died from cirrhosis or hepatocellular carcinoma caused by HCV infection. In May 2016, the World Health Assembly endorsed the Global Health Sector Strategy (GHSS) on...

no image available

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

To compare the risk for all cause and overdose mortality in people with opioid dependence during and after substitution treatment with methadone or buprenorphine and to characterise trends in risk of mortality after initiation and cessation of treatment.

.